THIS study was undertaken to evaluate the monocyte function of uraemic non-responders to hepatitis B vaccination. Therefore, some parameters concerning antigen processing by monocytes (Mo) as antigen presenting cells (APC) were analysed. It was found that in uraemic non-responders, (1) the internalization of HBsAg by monocytes was significantly decreasjed---HBsAg complexed with specific IgG or as immune complex isolated from patients is better internalized compared with free HBsAg; (2) during antigen presentation the expression of adhesion (ICAM-1) and accessory (HLA-DR/Ia) molecules was significantly decreased in uraemic patients, especially in non-responders; and (3) 
Introduction
After immunization with hepatitis B (HBV) vaccine, 95% of healthy individuals develop antibodies against hepatitis B surface antigen (HBsAg). In contrast, only 60-70% of dialysis patients show a seroconversion even after additional injections of the vaccine. Various attempts have been made to enhance antibody production and to clarify the causes of this lack of response. Recent studies have shown that in uraemic non-responders to HBV vaccination, T lymphocytes do not receive the monocyte-derived signals that are essential for adequate antigen presentation. In vitro, this defect can partially be counteracted by addition of monocytes from healthy donors [2] [3] [4] or simultaneous supplementation of IL-2, IL-1, IL-6 and IFN-/. 1, 5 In the present study we tested the monocyte internalization (phagocytic) capacity for HBsAg, as well as adhesion (ICAM-1/intercellular adhesion molecule-I) and accessory molecule (HLA-DR/Ia) expression on monocytes induced by HBsAg. The parameters examined were correlated with responsiveness to HBV vaccination in patients undergoing intermittent haemodialysis (ESRD patients).
Materials and Methods
Patients: This study was carried out according to the Declaration of Helsinki, and the informed consent of each patient was obtained. Thirty haemodialysis patients (20 males, ten females) who had not produced antibodies after at least four injections of H-B-Vax-D vaccine (U-NR, uraemic non-responders) and ten uraemic haemodialysis patients who had responded to the vaccine (U-R, uraemic responders; anti-HBs antibody titre higher than 10 U/l) were included in the study. Ten healthy volunteers who had responded well to HBV vaccination (C-R, control responder; anti-HBs antibody higher than 10 U/l) and ten healthy blood donors (C-NR, control nonresponders; Institute of Transfusiology, University of Cologne) not responding to vaccination were selected as control groups for the trial. The mean age of patients was 25.6 years (range years), the mean duration of haemodialysis was 3.1 years (range 1-6 years). The (Fig. 2) .
Results
Internalization activity of monocytes: Internalization of the HBsAg preparation by monocytes was measured by assessing phagocytic activity, using flow cytometry (Fig. 1) In conclusion, the parameters examined only partially involve the phenomena concerning monocyte antigen processing and presentation. Additional events should be taken into account for further investigations, e.g. intracellular processing of HBsAg following its internalization into monocytes, and a wider variety of adhesion and accessory molecules. Thus, further analysis of the precise mechanisms could lead to simultaneous administration of different cytokines to improve the impaired response to HBV vaccination in dialysis patients, by providing the co-stimulatory signal.
